Production (Stage)
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.74
-$0.09-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.15% | 30.86% | -37.87% | -44.91% | 14.00% |
| Total Depreciation and Amortization | -39.55% | -11.84% | 1.13% | -1.12% | 2.70% |
| Total Amortization of Deferred Charges | -- | -100.00% | -42.55% | -29.63% | -1.05% |
| Total Other Non-Cash Items | 47.01% | -38.82% | 479.65% | 262.95% | -88.65% |
| Change in Net Operating Assets | 60.78% | -25.74% | -514.81% | 132.90% | -250.25% |
| Cash from Operations | -50.07% | 21.52% | -55.91% | -12.25% | -32.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.59% | 156.82% | 6.53% | 83.27% | -1,045.67% |
| Cash from Investing | 107.59% | 156.82% | 6.53% | 83.27% | -1,045.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -380.85% | 2.19% | -5.13% |
| Issuance of Common Stock | -- | -- | 17.69% | -71.96% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.05% | -28.37% | -67.19% | 5,694.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 176.49% | 47.81% | -144.49% | 2,428.39% | -84.69% |